Transitioning From Descriptive to Mechanistic Understanding of the Microbiome: The Need for a Prospective Longitudinal Approach to Predicting Disease

Journal of Pediatrics

Volumn 179, Issue , 2016, Pages 240-248

  Martin, Victoria J ^a   Leonard, Maureen M ^a   Fiechtner, Lauren ^a   Fasano, Alessio ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

autoimmune disease; celiac disease; food allergy; inflammatory bowel disease; metabolomics; multi omic data integration; necrotizing enterocolitis; obesity; probiotics

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

ALLERGIC DISEASE; CELIAC DISEASE; CHILD; CHILDHOOD DISEASE; CHRONIC DISEASE; CHRONIC INFLAMMATION; FECAL MICROBIOTA TRANSPLANTATION; HUMAN; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; INTESTINE FLORA; NECROTIZING ENTEROCOLITIS; NOTE; OBESITY; PRIORITY JOURNAL; HYPERSENSITIVITY; MICROFLORA;

CELIAC DISEASE; CHILD; ENTEROCOLITIS, NECROTIZING; HUMANS; HYPERSENSITIVITY; INFLAMMATORY BOWEL DISEASES; MICROBIOTA; OBESITY;

EID: 84997402721     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2016.08.049     Document Type: Note

References (83)

1. 1 Bach, J.-F., The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347 (2002), 911–920.
2. 2 Greenwood, B.M., Autoimmune disease and parasitic infections in Nigerians. Lancet 2 (1968), 380–382.
3. 3 Strachan, D.P., Hay fever, hygiene, and household size. BMJ 299 (1989), 1259–1260.
4. 4 Versini, M., Jeandel, P.-Y., Bashi, T., Bizzaro, G., Blank, M., Shoenfeld, Y., Unraveling the hygiene hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications. BMC Med, 13, 2015, 81.
5. 5 Aagaard, K., Ma, J., Antony, K.M., Ganu, R., Petrosino, J., Versalovic, J., The placenta harbors a unique microbiome. Sci Transl Med, 6, 2014, 237ra65.
6. 6 Vicario, M., Blanchard, C., Stringer, K.F., Collins, M.H., Mingler, M.K., Ahrens, A., et al. Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut 59 (2010), 12–20.
7. 7 Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2 (2001), 361–367.
8. 8 Dominguez-Bello, M.G., Costello, E.K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107 (2010), 11971–11975.
9. 9 Azad, M.B., Konya, T., Maughan, H., Guttman, D.S., Field, C.J., Chari, R.S., et al. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ 185 (2013), 385–394.
10. 10 Yatsunenko, T., Rey, F.E., Manary, M.J., Trehan, I., Dominguez-Bello, M.G., Contreras, M., et al. Human gut microbiome viewed across age and geography. Nature 486 (2012), 222–227.
11. 11 Penders, J., Thijs, C., van den Brandt, P.A., Kummeling, I., Snijders, B., Stelma, F., et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 56 (2007), 661–667.
12. 12 Jackson, K.D., Howie, L.D., Akinbami, L.J., Trends in allergic conditions among children: United States, 1997-2011. NCHS Data Brief 121 (2013), 1–8.
13. 13 Chinthrajah, R.S., Hernandez, J.D., Boyd, S.D., Galli, S.J., Nadeau, K.C., Molecular and cellular mechanisms of food allergy and food tolerance. J Allergy Clin Immunol 137 (2016), 984–997.
14. 14 Ventura, M.T., Polimeno, L., Amoruso, A.C., Gatti, F., Annoscia, E., Marinaro, M., et al. Intestinal permeability in patients with adverse reactions to food. Dig Liver Dis 38 (2006), 732–736.
15. 15 Perrier, C., Corthésy, B., Gut permeability and food allergies. Clin Exp Allergy 41 (2011), 20–28.
16. 16 Torgerson, T.R., Linane, A., Moes, N., Anover, S., Mateo, V., Rieux-Laucat, F., et al. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Gastroenterology 132 (2007), 1705–1717.
17. 17 Toit Du, G., Roberts, G., Sayre, P.H., Bahnson, H.T., Radulovic, S., Santos, A.F., et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med 372 (2015), 803–813.
18. 18 Ling, Z., Li, Z., Liu, X., Cheng, Y., Luo, Y., Tong, X., et al. Altered fecal microbiota composition associated with food allergy in infants. Appl Environ Microbiol 80 (2014), 2546–2554.
19. 19 Ege, M.J., Mayer, M., Normand, A.-C., Genuneit, J., Cookson, W.O.C.M., Braun-Fahrländer, C., et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med 364 (2011), 701–709.
20. 20 Azad, M.B., Konya, T., Guttman, D.S., Field, C.J., Sears, M.R., HayGlass, K.T., et al. Infant gut microbiota and food sensitization: associations in the first year of life. Clin Exp Allergy 45 (2015), 632–643.
21. 21 Stefka, A.T., Feehley, T., Tripathi, P., Qiu, J., McCoy, K., Mazmanian, S.K., et al. Commensal bacteria protect against food allergen sensitization. Proc Natl Acad Sci USA 111 (2014), 13145–13150.
22. 22 Berni Canani, R., Sangwan, N., Stefka, A.T., Nocerino, R., Paparo, L., Aitoro, R., et al. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME J 10 (2016), 742–750.
23. 23 Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504 (2013), 451–455.
24. 24 Schuppan, D., Current concepts of celiac disease pathogenesis. Gastroenterology 119 (2000), 234–242.
25. 25 Laparra, J.M., Sanz, Y., Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion. J Cell Biochem 109 (2010), 801–807.
26. 26 Lindfors, K., Blomqvist, T., Juuti-Uusitalo, K., Stenman, S., Venäläinen, J., Mäki, M., et al. Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin Exp Immunol 152 (2008), 552–558.
27. 27 Wacklin, P., Kaukinen, K., Tuovinen, E., Collin, P., Lindfors, K., Partanen, J., et al. The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflamm Bowel Dis 19 (2013), 934–941.
28. 28 Di Cagno, R., De Angelis, M., De Pasquale, I., Ndagijimana, M., Vernocchi, P., Ricciuti, P., et al. Duodenal and faecal microbiota of celiac children:molecular, phenotype and metabolome characterization. BMC Microbiol, 11, 2011, 219.
29. 29 Tjellström, B., Stenhammar, L., Högberg, L., Fälth-Magnusson, K., Magnusson, K.-E., Midtvedt, T., et al. Screening-detected and symptomatic untreated celiac children show similar gut microflora-associated characteristics. Scand J Gastroenterol 45 (2010), 1059–1062.
30. 30 Olivares, M., Neef, A., Castillejo, G., Palma, G.D., Varea, V., Capilla, A., et al. The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease. Gut 64 (2015), 406–417.
31. 31 Sellitto, M., Bai, G., Serena, G., Fricke, W.F., Sturgeon, C., Gajer, P., et al. Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS ONE, 7, 2012, e33387.
32. 32 Lionetti, E., Castellaneta, S., Francavilla, R., Pulvirenti, A., Tonutti, E., Amarri, S., et al. Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med 371 (2014), 1295–1303.
33. 33 Vriezinga, S.L., Auricchio, R., Bravi, E., Castillejo, G., Chmielewska, A., Crespo Escobar, P., et al. Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med 371 (2014), 1304–1315.
34. 34 Leonard, M.M., Camhi, S., Huedo-Medina, T.B., Fasano, A., Celiac Disease Genomic, Environmental, Microbiome, and Metabolomic (CDGEMM) study design: approach to the future of personalized prevention of celiac disease. Nutrients 7 (2015), 9325–9336.
35. 35 Corridoni, D., Arseneau, K.O., Cifone, M.G., Cominelli, F., The dual role of nod-like receptors in mucosal innate immunity and chronic intestinal inflammation. Front Immunol, 5, 2014, 317.
36. 36 Barclay, A.R., Morrison, D.J., Weaver, L.T., What is the role of the metabolic activity of the gut microbiota in inflammatory bowel disease? Probing for answers with stable isotopes. J Pediatr Gastroenterol Nutr 46 (2008), 486–495.
37. 37 Khor, B., Gardet, A., Xavier, R.J., Genetics and pathogenesis of inflammatory bowel disease. Nature 474 (2011), 307–317.
38. 38 Manichanh, C., Borruel, N., Casellas, F., Guarner, F., The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 9 (2012), 599–608.
39. 39 Gevers, D., Kugathasan, S., Denson, L.A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15 (2014), 382–392.
40. 40 Morgan, X.C., Tickle, T.L., Sokol, H., Gevers, D., Devaney, K.L., Ward, D.V., et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol, 13, 2012, R79.
41. 41 Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55 (2006), 205–211.
42. 42 Seksik, P., Rigottier-Gois, L., Gramet, G., Sutren, M., Pochart, P., Marteau, P., et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52 (2003), 237–242.
43. 43 Willing, B.P., Dicksved, J., Halfvarson, J., Andersson, A.F., Lucio, M., Zheng, Z., et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139 (2010), 1844–1854 e1.
44. 44 Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening-Baucke, V., Ortner, M., et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 122 (2002), 44–54.
45. 45 Chassaing, B., Koren, O., Goodrich, J.K., Poole, A.C., Srinivasan, S., Ley, R.E., et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519 (2015), 92–96.
46. 46 Negroni, A., Costanzo, M., Vitali, R., Superti, F., Bertuccini, L., Tinari, A., et al. Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 18 (2012), 913–924.
47. 47 Michail, S., Durbin, M., Turner, D., Griffiths, A.M., Mack, D.R., Hyams, J., et al. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis 18 (2012), 1799–1808.
48. 48 Groer, M.W., Luciano, A.A., Dishaw, L.J., Ashmeade, T.L., Miller, E., Gilbert, J.A., Development of the preterm infant gut microbiome: a research priority. Microbiome, 2, 2014, 38.
49. 49 Uauy, R.D., Fanaroff, A.A., Korones, S.B., Phillips, E.A., Phillips, J.B., Wright, L.L., Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 119 (1991), 630–638.
50. 50 Fitzgibbons, S.C., Ching, Y., Yu, D., Carpenter, J., Kenny, M., Weldon, C., et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg 44 (2009), 1072–1075 discussion 1075-6.
51. 51 Claud, E.C., Walker, W.A., Bacterial colonization, probiotics, and necrotizing enterocolitis. J Clin Gastroenterol, 42(suppl 2), 2008 S46-52.
52. 52 Viscardi, R.M., Lyon, N.H., Sun, C.C., Hebel, J.R., Hasday, J.D., Inflammatory cytokine mRNAs in surgical specimens of necrotizing enterocolitis and normal newborn intestine. Pediatr Pathol Lab Med 17 (1997), 547–559.
53. 53 Halpern, M.D., Holubec, H., Dominguez, J.A., Williams, C.S., Meza, Y.G., McWilliam, D.L., et al. Up-regulation of IL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitis. Pediatr Res 51 (2002), 733–739.
54. 54 Harris, M.C., D'Angio, C.T., Gallagher, P.R., Kaufman, D., Evans, J., Kilpatrick, L., Cytokine elaboration in critically ill infants with bacterial sepsis, necrotizing entercolitis, or sepsis syndrome: correlation with clinical parameters of inflammation and mortality. J Pediatr 147 (2005), 462–468.
55. 55 Seitz, G., Warmann, S.W., Guglielmetti, A., Heitmann, H., Ruck, P., Kreis, M.E., et al. Protective effect of tumor necrosis factor alpha antibody on experimental necrotizing enterocolitis in the rat. J Pediatr Surg 40 (2005), 1440–1445.
56. 56 Morowitz, M.J., Poroyko, V., Caplan, M., Alverdy, J., Liu, D.C., Redefining the role of intestinal microbes in the pathogenesis of necrotizing enterocolitis. Pediatrics 125 (2010), 777–785.
57. 57 Warner, B.B., Deych, E., Zhou, Y., Hall-Moore, C., Weinstock, G.M., Sodergren, E., et al. Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study. Lancet 387 (2016), 1928–1936.
58. 58 Colaizy, T.T., Bartick, M.C., Jegier, B.J., Green, B.D., Reinhold, A.G., Schaefer, A.J., et al. Impact of optimized breastfeeding on the costs of necrotizing enterocolitis in extremely low birthweight infants. J Pediatr 175 (2016), 100–105 e2.
59. 59 Neu, J., Necrotizing enterocolitis: the mystery goes on. Neonatology 106 (2014), 289–295.
60. 60 World Health Organization, WHO global strategy on diet, physical activity and health. 2006, WHO, Geneva, Switzerland.
61. 61 Mueller, N.T., Whyatt, R., Hoepner, L., Oberfield, S., Dominguez-Bello, M.G., Widen, E.M., et al. Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int J Obes (Lond) 39 (2015), 665–670.
62. 62 Cannon, M.V., Buchner, D.A., Hester, J., Miller, H., Sehayek, E., Nadeau, J.H., et al. Maternal nutrition induces pervasive gene expression changes but no detectable DNA methylation differences in the liver of adult offspring. PLoS ONE, 9, 2014, e90335.
63. 63 Gluckman, P.D., Hanson, M.A., Living with the past: evolution, development, and patterns of disease. Science 305 (2004), 1733–1736.
64. 64 Bateson, P., Gluckman, P., Hanson, M., The biology of developmental plasticity and the Predictive Adaptive Response hypothesis. J Physiol 592 (2014), 2357–2368.
65. 65 Bergström, A., Skov, T.H., Bahl, M.I., Roager, H.M., Christensen, L.B., Ejlerskov, K.T., et al. Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants. Appl Environ Microbiol 80 (2014), 2889–2900.
66. 66 Fallani, M., Amarri, S., Uusijarvi, A., Adam, R., Khanna, S., Aguilera, M., et al. Determinants of the human infant intestinal microbiota after the introduction of first complementary foods in infant samples from five European centres. Microbiology (Reading, Engl) 157:Pt 5 (2011), 1385–1392.
67. 67 Matamoros, S., Gras-Leguen, C., Le Vacon, F., Potel, G., de La Cochetiere, M.-F., Development of intestinal microbiota in infants and its impact on health. Trends Microbiol 21 (2013), 167–173.
68. 68 Bailey, L.C., Forrest, C.B., Zhang, P., Richards, T.M., Livshits, A., DeRusso, P.A., Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr 168 (2014), 1063–1069.
69. 69 Gerber, J.S., Bryan, M., Ross, R.K., Daymont, C., Parks, E.P., Localio, A.R., et al. Antibiotic exposure during the first 6 months of life and weight gain during childhood. JAMA 315 (2016), 1258–1265.
70. 70 Korpela, K., Salonen, A., Virta, L.J., Kekkonen, R.A., de Vos, W.M., Association of early-life antibiotic use and protective effects of breastfeeding. JAMA Pediatr 170 (2016), 750–757.
71. 71 Cox, L.M., Yamanishi, S., Sohn, J., Alekseyenko, A.V., Leung, J.M., Cho, I., et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158 (2014), 705–721.
72. 72 Mahana, D., Trent, C.M., Kurtz, Z.D., Bokulich, N.A., Battaglia, T., Chung, J., et al. Antibiotic perturbation of the murine gut microbiome enhances the adiposity, insulin resistance, and liver disease associated with high-fat diet. Genome Med, 8, 2016, 48.
73. 73 Committee on Accelerating Progress in Obesity Prevention Food and Nutrition Board Institute of Medicine, Glickman, D., Parker, L., Sim, L.J., et al. Accelerating progress in obesity prevention: solving the weight of the nation. 2012, National Academies Press (US), Washington (DC).
74. 74 Juneau, M., Hayami, D., Gayda, M., Lacroix, S., Nigam, A., Provocative issues in heart disease prevention. Can J Cardiol, 30(12 suppl), 2014 S401-9.
75. 75 Suhre, K., Meisinger, C., Döring, A., Altmaier, E., Belcredi, P., Gieger, C., et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE, 5, 2010, e13953.
76. 76 Palau-Rodriguez, M., Tulipani, S., Isabel Queipo-Ortuño, M., Urpi-Sarda, M., Tinahones, F.J., Andres-Lacueva, C., Metabolomic insights into the intricate gut microbial-host interaction in the development of obesity and type 2 diabetes. Front Microbiol, 6, 2015, 1151.
77. 77 Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., et al. Population-level analysis of gut microbiome variation. Science 352 (2016), 560–564.
78. 78 Costeloe, K., Hardy, P., Juszczak, E., Wilks, M., Millar, M.R., Probiotics in Preterm Infants Study Collaborative Group. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 387 (2016), 649–660.
79. 79 Lee, C.H., Steiner, T., Petrof, E.O., Smieja, M., Roscoe, D., Nematallah, A., et al. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent clostridium difficile infection: a Randomized Clinical Trial. JAMA 315 (2016), 142–149.
80. 80 Hourigan, S.K., Oliva-Hemker, M., Fecal microbiota transplantation in children: a brief review. Pediatr Res 80 (2016), 2–6.
81. 81 Bowman, K.A., Broussard, E.K., Surawicz, C.M., Fecal microbiota transplantation: current clinical efficacy and future prospects. Clin Exp Gastroenterol 8 (2015), 285–291.
82. 82 Collins, S.M., Kassam, Z., Bercik, P., The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Curr Opin Microbiol 16 (2013), 240–245.
83. 83 Franzosa, E.A., Morgan, X.C., Segata, N., Waldron, L., Reyes, J., Earl, A.M., et al. Relating the metatranscriptome and metagenome of the human gut. Proc Natl Acad Sci USA, 111, 2014 E2329-38.